BIOMARKERS FOR BREAST CANCER PATIENTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140302515A1
SERIAL NO

13571106

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Kaiso, a transcriptional regulator with bimodal DNA-binding specificity, is over-expressed in breast cancer cells, and its nuclear localization is correlated with malignant and lymph node metastasis. Depleted expression of Kaiso in those cells results in a significant decrease in basal and EGF-induced cell migration, and this is associated with increased E-cadherin expression. The data reported and described herein provide significant evidence that Kaiso is involved in breast cancer invasion and metastasis. Kaiso nuclear localization is a biomarker that is associated with invasive and metastatic infiltrating ductal breast cancer that may be used to monitor, detect, and/or track the progress of disease in a patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TUSKEGEE UNIVERSITY103 CHAPPIE JAMES CENTER TUSKEGEE AL 36088

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jones-Triche, Jacqueline Tuskegee, US 1 0
Turner, Timothy Auburn, US 34 632
Yates, Clayton Auburn, US 14 33

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation